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Rat  serum  albumin  has  been  labeled with dilactitol- 
lZ5I-tyramine, (12‘I-DLT) a radioactive tracer which 
remains  entrapped within lysosomes following cellular 
uptake  and  degradation  of  the  carrier  protein.  Similar 
kinetics of clearance from the rat circulation were 
observed  for  albumin  labeled  conventionally with lZsI 
or  12‘I-DLT-albumin,  both  proteins having circulating 
half-lives of -2.2 days. In contrast, the recovery of 
whole body radioactivity had half-lives of -2.2 and 
5.1 days, respectively, for the two protein prepara- 
tions, indicating  substantial  retention of  degradation 
products derived from catabolism of ”‘I-DLT-albu- 
min.  Measurement  of  total  and  acid-soluble  radioactiv- 
ity in tissues 2 or 4 days after injection of ”‘1-DLT- 
albumin revealed that skin and  muscle  accounted  for 
the  largest  fraction (50-60%) of  degradation  products 
in the  body.  Fibroblasts were identified by  autoradiog- 
raphy as the major cell type containing radioactive 
degradation  products  in skin and  muscle.  Fibroblasts 
were isolated  from skin by  collagenase digestion, fol- 
lowed  by  density  gradient  centrifugation.  The  amount 
of  acid-soluble radioactivity recovered  in  these cells 
was in excellent agreement with that  predicted  based 
on  acid  precipitation  of  solubilized  whole skin prepa- 
rations.  These studies demonstrate for the first time 
that  fibroblasts are a major cell type  involved  in  the 
degradation  of  albumin in vivo. 
A general aim of research in our laboratory  is to characterize 
the mechanisms regulating the catabolism of plasma proteins. 
As a first  step, we set  out  to  determine the tissue  and cellular 
sites of uptake and degradation of these proteins. Identifica- 
tion of the  sites of degradation of proteins with the relatively 
long circulating half-lives characteristic of plasma  proteins 
relies on  the use of radioactive tracers which remain  entrapped 
in cellular lysosomes after  the protein  carrier  has been de- 
graded to diffusible catabolites. In previous work we evaluated 
the tissue  sites of albumin catabolism in normal rats using 
[3H]raffinose as a residualizing tracer (1). The  data from that 
study  indicated that  the majority of albumin catabolism took 
place diffusely throughout the body, primarily in skin and 
muscle.  However, because of both  the low specific activity of 
the 3H isotope and  the low efficiency of coupling of the label 
to protein, it was difficult to carry out autoradiographic stud- 
ies to identify the cell types involved in albumin degradation. 
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search Grant AM-25373 (to. S. R. T.) and Research Career Devel- 
opment Award AM-00931 (to J. W. B.). The costs of publication of 
this article were defrayed in  part by the payment of page charges. 
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accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 
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In  the present study, we have used a newly  developed (2) high 
specific activity iodinated ligand, dilactit~l-’~~I-tyramine (‘“I- 
DLT’), as  the residualizing tracer, and present evidence that 
the fibroblast is a major cell type involved in  the catabolism 
of albumin in  peripheral tissue. 
MATERIALS AND METHODS 
Bovine serum albumin, NaBH&N, glutamine, erythrosin B, 
DNase I, and metrizamide (2-[3-acetamido-5-N-methylacetamido- 
2,4,6-triiodobenzamido]-2-deoxy-~-glucose) were purchased from 
Sigma and N a T  from New England Nuclear. Ham’s F-10 medium 
with glutamine, fetal calf serum, penicillin (5000 IU/ml)/streptomy- 
cin (5000 pglml), and fungizone (250 pg/ml)  were obtained from KC 
Biological, Inc., Lenexa, KS. Complete medium consisted of 0.12% 
NaHC03, 1% each penicillin, streptomycin, fungizone, and glutamine, 
10% fetal calf serum, and 20 mM HEPES in Ham’s F-10 medium, 
adjusted to  pH 7.4. DNase, 0.4%, was prepared  in Caz+- and M e -  
free  Hanks’ salt solution. 
Preparation  and Labeling of AZbumin-Rat serum albumin (RSA) 
was purified from fresh rat serum by a series of chromatographic 
steps: affinity chromatography on Affi-Gel Blue (Bio-Rad), followed 
by ion-exchange chromatography on Whatman DE 52  (3), and finally, 
gel exclusion chromatography on Sephacryl S-200 (Pharmacia) eluted 
with phosphate-buffered saline (137 mM NaC1, 2.7 mM KC1,8.1 mM 
Na2HPO4, 1.7 mM KHzPO4). The purity of albumin preparations was 
evaluated after sodium dodecyl sulfate-polyacrylamide gel electropho- 
resis under  denaturing conditions (4) and was typically >95%, both 
qualitatively by Coomassie Blue staining and quantitatively by slicing 
and counting gel lanes  containing lZ5I-labeled albumin. 
RSA was iodinated directly with NalZ5I using Iodogen (Pierce) as 
previously described (31, or with the residualizing tracer lZ5I-DLT. 
The synthesis, iodination, and coupling of this label to protein have 
been described in detail elsewhere (2). Briefly, the lZ5I-DLT (10 nmol, 
0.9 mCi) was treated with galactose oxidase to generate terminal 
aldehyde groups, and  the oxidized ligand then coupled to protein (2 
mg, 29 nmol) by reductive amination using NaBH3CN. Labeled 
protein was separated from unbound ‘Y-DLT by dialysis against 0.1 
M NH&l for 1 h at room temperature, followed by an overnight 
dialysis a t  4 “C against several changes of phosphate-buffered saline. 
About 70% of added label was attached to protein, giving a final 
specific activity of -0.3 pCi/pg, 0.02 Ci/pmol. The final labeled 
protein preparation was >97% precipitable in 10% trichloroacetic 
acid. Radioactivity was measured in a Tracor Analytic Model 1190 y 
counter. 
In Vivo Experiments-Sprague-Dawley rats, male and female, 150- 
200 g, were fed ad libitum and maintained on water containing 0.025% 
NaI (3). Animals were injected intracardially with radiolabeled pro- 
teins, and  the kinetics of clearance of protein from the circulation 
was determined from measurement of radioactivity in plasma aliquots 
taken at  desired time intervals. Clearance of radioactivity from the 
whole body was determined in a well-type y counter as described 
previously (31, and/or by measuring radioactivity recovered in excreta 
from  animals  maintained  in metabolic cages. 
Determination of Total  and  Acid-soluble  Radioactivity in Tissues- 
Animals were killed by overanesthetizing with ether  and perfused 
The abbreviations used are: ‘%I-DLT, dilactitol-1251-tyramine; 
HEPES, 4-(2-hydroxyethyl)-l-piperazineethane sulfonic acid; RSA, 
rat serum albumin. 
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with iced saline, and tissues were  removed. Total recovered radioac- 
tivity in various tissues was determined by measuring radioactivity 
in weighed aliquots and multiplying by total organ weight; total tissue 
weights for muscle, skin,  fat, and bone were calculated as per cent of 
body weight, based on published values (5, 6). The extent of protein 
degradation was estimated by determining the amount of radioactivity 
in tissues soluble in 20% trichloroacetic acid. The procedures for acid 
precipitation of tissues are essentially those described previously in 
experiments using [3H]raffinose-labeled RSA (l), except that samples 
were counted directly, without the need for decolorizing or  scintilla- 
tion fluid. For  soft tissues, precipitations were carried out on aliquots 
(usually 0.2 ml) of homogenates prepared in 2-3 volumes (w/v) of 
water; for muscle and skin,  precipitations were carried out on NaOH 
extracts of the tissues (1). In control experiments, mixtures of labeled 
protein and extracted degradation products were added to tissue 
extracts from uninjected animals prior to acid precipitation. The 
recovery of acid-soluble and precipitable radioactivity agreed closely 
(>go%) with that predicted on the basis of the known distribution of 
radioactivity in the  starting mixture. 
Autoradiographic Studies-For autoradiographic studies, 80-120 g 
animals were injected with 0.3-0.5 mCi of lZ5I-DLT-RSA. Animals 
were killed at various times, and tissues were  removed as rapidly as 
possible, cut  into 1-mm pieces, and fixed overnight in 2% glutaral- 
dehyde (Ted Pella, Inc., Tostin, CA) in phosphate-buffered saline. 
The samples were then dehydrated  through graded alcohol solutions 
(70-95%) and embedded in Sorvall JB4 methacrylate according to 
the manufacturer’s directions. Recovery of radioactivity in tissue 
samples  through the fixation and embedding steps was 290%. Tissue 
blocks were cut  into 2-3-micron sections, placed on glass slides, and 
dipped in Kodak Nuclear Track Emulsion, type NTB2. Autoradi- 
ograms developed after 2-3 weeks showed excellent visualization of 
grains over cells. 
Isolation of Cells Containing Radioactive Degradation Products from 
Rat Skin-Cell isolations were carried out 4 days post-injection of 
’”I-DLT-RSA. The animal was anesthetized, and  an area of abdom- 
inal  skin -10 X 8 cm was shaved first with fur clippers and  then with 
a straight razor to remove all visible hair. The shaved area was 
swabbed with 70% ethanol and  the  rat  then killed and perfused as 
above. A large section (-5 X 5 cm) of shaved skin was then surgically 
separated from the muscle layer. After this point, all procedures were 
carried  out in a  laminar flow hood and  in sterile  containers. The piece 
of skin was rinsed in a solution of penicillin, streptomycin, and 
fungizone and  then  attached with staples to a 4 X 4-cm plastic weigh 
boat with the dermal surface facing down. 
The skin attached  to  the weigh boat was digested by sequential 
treatments with 2 ml of a collagenase (Worthington) solution. For 
the 1st h of digestion, the enzyme solution contained 0.4% collagenase 
in complete medium supplemented with an additional 4% penicillin, 
streptomycin, and fungizone; for the subsequent half-hour digestions, 
the enzyme solution contained 0.25% collagenase in  the same me- 
dium. The collagenase digestion mixture was pipetted  underneath the 
skin into  the weigh boat, which was then placed inside a covered 
Petri dish in a 37 “C shaking water bath (70-80 oscillations/min). At 
the  end of each digestion period, the collagenase extract was removed, 
and a  fresh aliquot of the enzyme solution was added to  the weigh 
boat. Each digest was centrifuged at room temperature for 4-5 min 
at  150 X g in an IEC Centra 7R centrifuge. The  supernatant was 
removed, and  the cell pellet was resuspended in a mixture of  0.8  ml 
of complete medium and 0.2 ml of DNase solution and washed by 
recentrifugation. Supernatants  and cell pellets were counted  for ra- 
dioactivity; the number of cells was determined using a hemocytom- 
eter  and cell viability based on exclusion of the dye erythrosin B. 
Fractionation of Isolated Cells by Density Gradient  Centrifugation- 
An 8-ml continuous density gradient from 2 to 25% metrizamide in 
complete medium was prepared  in a 1.2 X 11.2-cm  Corex (Corning) 
centrifuge tube which had been silanized with dichlorodimethylsilane 
(Sigma). An aliquot, 0.8 ml, of a resuspended cell pellet from a 
collagenase digest of skin was layered onto the  top of the gradient, 
and  the tube centrifuged at  room temperature at 700 X g for 10 min 
in an IEC  Centra 7R centrifuge. At the end of the centrifugation, the 
top 0.8-ml sample volume was removed, and the gradient  separated 
into sequential 1-ml aliquots thereafter. Radioactivity and cell num- 
ber were determined for each fraction as described above. 
RESULTS 
Kinetics of Albumin Clearance from the Circulation and 
Whole Body-To verify that  attachment of lZ5I-DLT did not 
affect the normal circulating half-life of RSA, a comparison 
was made of the kinetics of clearance from the circulation of 
RSA labeled conventionally with lZ5I and labeled with lZ5I- 
DLT using reductive amination. As shown in the upper part 
of Fig. 1, the  rate of loss of radioactivity from plasma was 
similar for RSA, irrespective of the labeling procedures. The 
circulating half-life of RSA, extrapolated from the linear 
portion of the clearance curves, is about 2.2 days, in agreement 
with previously reported values (1, 3). The y intercept of the 
extrapolated clearance curves is at 28%, indicating an approx- 
imate 3.51  distribution for albumin between extra-  and intra- 
vascular compartments, again in agreement with typical val- 
ues. Although the kinetics of clearance from plasma are 
similar, the kinetics of loss of radioactivity from the whole 
body are significantly different for albumin labeled either 
directly with ‘‘‘I or with the residualizing tracer lz5I-DLT. 
The whole  body and plasma half-lives of directly labeled lZ5I- 
RSA are the same (Fig. 1) as expected, since radioactive 
t, = 5.1 days 
WHOLE BODY 
2 4 6 
TIME (days) 
FIG. 1. Kinetics of clearance of various 12%labeled RSA 
preparations from the  rat  circulation and whole body. Animals 
were injected with 2-3 X lo6 cpm (510 pg) of RSA labeled by direct 
iodination (X) or with lZ6I-DLT (0). Whole body radioactivity and 
radioactivity in plasma were determined as described under “Mate- 
rials and Methods.” 
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catabolites  are rapidly excreted from the body in urine follow- 
ing degradation of 1251-protein (3). In contrast, radioactivity 
from lZ5I-DLT-RSA was lost from the whole  body with a half- 
life of about 5.1 days, compared to its circulating half-life of 
2.2 days, indicating that  substantial  amounts of radioactivity 
from degraded protein were being retained  in the body. 
Tissue Distribution of Recovered Radioactivity-Table I 
summarizes the recovery of radioactivity in various body 
organs at  2 and 4 days after injection of ‘“1-DLT-RSA. These 
times were chosen for study because approximately 50 and 
70% of injected protein  had been catabolized, based on first 
order  kinetics and a half-life of 2.2 days. The  data  in Column 
1 indicate that  the majority of radioactivity recovered in  the 
body, exclusive of blood,  was in  skin  and muscle. As shown in 
Column 2, for skin, muscle, and adipose tissue, the  amount of 
acid-soluble radioactivity (degradation products) increased 
from 30-50% at 2 days to about 50-70% at 4 days after 
injection. Skin  and muscle accounted for 50-60% of catabol- 
ized dose retained  in the body (Column 3), similar to results 
obtained using [3H]raffinose-RSA (1). Adipose tissue was not 
studied previously, but with the greater sensitivity obtained 
in the present experiments, it is clear that a measurable 
fraction of albumin catabolism occurred in that tissue. 
Total excreted radioactivity accounted for an average of 21 
and 41% of administered dose at  2 and 4 days post-injection, 
respectively. A significant fraction, 20-25% of excreted radio- 
activity, was recovered in feces, whereas none had been de- 
tected  in feces using the [3H]raffinose label (1). It is possible 
that  the radioactivity in feces may result from protein degra- 
dation  in hepatocytes, followed  by release of catabolites  into 
bile. If the acid-soluble radioactivity in liver and feces is 
summed, the  total amount of albumin degradation in liver 
may be as much as 10-12%. It is difficult to reach firm 
conclusions regarding the origin of radioactivity in feces, since 
TABLE I 
Recovery of radioactivity  and  extent of protein catabolism in tissues 
following  injection  of  lZ5Z-DLT-RSA in rats 
Animals were injected with -20 X lo6 cpm (90 pg) of lZ5I-DLT- 
RSA  and killed  at 2 or 4 days  post-injection.  Total  and  acid-soluble 
and  Methods.” 
radioactivity in tissues was  determined as described  under  “Materials 
Tissue 
Time  post-injection 
2 days 4 days 2 days 4 days 2 days 4 days 
% cpm recovered in % acid-soluble %protein 
body” radioactivity  catabolizedb 
Blood 20.9 13.6 f 1.6 5 3   5 3  
Liver 7.8 8.4 f 0.9 85.5 86.4 f 3 6.7 7.3 
Kidney 4.3 4.7 f 0.2  83 88.5 f 1 3.6 4.1 
Spleen 0.5 0.7 k 0.1 71.5 85.6 k 1.1 0.36 0.6 
Fat 6.9 8.6 f 1.3  54  71. f 3.6 3.7 6.2 
Bones 4.4 4.9 f 0.7 53.5 64.8 f 2.6 2.4 3.2 
Heart 0.4 0.36 f 0.02 42.5 66.2 f 3.6 0.17 0.23 
Muscle 22.3 23.3 f 1.2 32.5 53.0 f 1.8 7.3 12.4 
Skin 28.2 31.9 f 3.5  44.3 64.6 f 2.1 12.5 20.6 
Other‘ 3.8  4.4 f 1.1 NDd ND 
Data  are expressed as per cent of radioactivity  recovered  in  the 
body,  which  represented an average of 79 and 59% of administered 
dose at 2 and 4 days  post-injection,  respectively (See Fig. 1). The sum 
of recovered dose in tissues and excreta was 100 f 6% of injected 
dose.  Data at 2-day time points are the average  values  for  two  animals; 
data  at  4-day  time points are for four animals  and are  expressed  as 
mean f S.D. 
Per cent protein  catabolized  was  determined by  multiplying the 
average  per cent recovered  dose  (Column 1) by the average  per cent 
acid-soluble  radioactivity  (Column 2). 
e Other:  lung, adrenals,  thymus,  stomach  and contents, and intes- 
tine and contents. 
ND = not  determined. 
previous studies have shown that a  fraction of degradation 
products  arising  in  non-hepatic tissue can be excreted in feces 
(2). Since most degradation products released from the body 
were recovered in urine, it is possible that  the small percentage 
(4%) of catabolites recovered in  renal tissue may not  result 
from actual catabolism of albumin in kidney, but  rather from 
resorption of degradation products, as was observed with 
degradation products from [3H]raffinose-labeled proteins (1). 
Autoradiographic Studies-A major purpose for using the 
high specific activity lZ5I-DLT label was to carry out  autora- 
diographic studies of tissues active in albumin catabolism. 
Rats were injected with lZ5I-DLT-RSA and killed 2 or 4 days 
later.  There were no qualitative differences in the distribution 
of grains in autoradiograms of tissues from the two time 
points.  Photographs of tissues from 4-day animals  are shown 
in Fig. 2, a-d, since somewhat more of the radioactivity in 
skin and muscle is in acid-soluble form, i.e. from degraded 
protein, at this  time  (Table I). 
There were striking concentrations of silver grains over 
fibroblasts in skin (Fig. 2, a  and b) and muscle  (Fig. 2, c and 
d), although clearly not every fibroblast was labeled. The 
identification of these cells as fibroblasts is based on both 
morphological criteria, i.e. their elongated nuclei and thin 
cytoplasm, and  on location in  the tissue, i.e. in  the ground 
substance of the dermis and  in  the interstitial region between 
myocytes in muscle. Besides the concentrations of grains over 
cells, some label was scattered diffusely in  the ground sub- 
stance in dermis and over myocytes.  We interpret the grains 
over fibroblasts to be derived from degradation products in- 
side these cells, whereas the diffuse background of grains 
would result from the fraction of acid-precipitable, unde- 
graded protein  in extracellular fluid. Although vascular en- 
dothelia have been proposed (7)  as possible sites of plasma 
protein degradation, grains were not observed over endothelial 
cells in  any of our sections (see Fig. 2b as an example). Thus, 
either these cells do not play a role in the degradation of 
albumin, or degradation products were lost from these cells 
at a significantly greater rate  than from fibroblasts. Overall, 
the autoradiographic studies suggest that fibroblasts are a 
major site of albumin catabolism in  the body. These cells are 
found diffusely throughout the body, consistent with the 
broad tissue  distribution of degradation products in our ex- 
periments  (Table I). 
Finally, although examined, sections of kidney and liver are 
not presented since, as discussed above, it is unclear what 
proportion of the radioactivity in these  tissues arises from in 
situ catabolism of albumin, compared to uptake of degradation 
products released from other tissues. In kidney, there were 
only sparse numbers of grains associated with glomeruli or in 
interstitial regions;  however, there were relatively heavy con- 
centrations of grains over cells of proximal tubules, suggesting 
that  the cellular radioactivity may indeed result from resorp- 
tion of degradation products. In liver, silver grains were 
distributed in a diffuse fashion and not localized over any 
unique cell type. 
Isolation of Fibroblasts Containing 1251--labeled Degradation 
Products-Based on the autoradiographic studies, we next 
attempted to isolate fibroblasts containing radioactive deg- 
radation  products from the skin of animals injected with lZ5I- 
DLT-RSA. Significant yields of intact cells containing radio- 
activity were obtained routinely by sequential 30-min colla- 
genase digestions of skin,  as described under “Materials  and 
Methods.” The  data  in Table I1  show that -10% of the  total 
skin radioactivity (Column 2) was released during each diges- 
tion period, and an average of -60% of the released radioac- 
tivity was  recovered in  the washed cell pellet (Column 3). The 
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FIG. 2. Autoradiograms of tissues  taken 4 days  after  injection of 300 pCi of lZ6I-DLT-RSA  into  an 
85-g rat. Tissues were processed for autoradiography as described under "Materials and Methods," and slides 
developed after 3 weeks. a, a typical section of dermis shows the dense concentration of silver grains over some 
fibroblasts (arrows) while numerous other fibroblasts remain unlabeled (arrow heads). Grains are only diffusely 
distributed over the extracellular matrix of collagen fibers and ground substance (X230). b, a view of dermis 
adjacent to skeletal muscle (srn). Note the heavy concentration of silver grains over the fibroblasts (arrow) in 
dermis and muscle (arrow  head), but the absence of grains over the endothelium lining the blood vessels (0). 
( ~ 2 9 0 ) .  c and d ,  low (X290) and high (X580) magnifications of skeletal muscle. Many of the fibroblasts located 
between adjacent myocytes are heavily labeled (arrows). As was seen in skin,  not all fibroblasts are labeled. Neither 
myocyte nuclei (arrow  heads in d )  nor cytoplasm shows accumulation of silver grains. 
digestion procedure generally released 50-70% of the total 
radioactivity in  the  skin sample  during  a 3.5-h period. The 
number of cells in each harvest varied from 1 to 2 X IO6, and 
the cells were >97% viable based on exclusion of the dye, 
erythrosin B. As a  control for fibroblast lysis in  the collagen- 
ase extracts, a known number of cultured fibroblasts was 
added to a digest of skin  and incubated for 30 min at 37 "C. 
In this experiment, 100 & 10% of the added cells was re- 
covered, making it likely that  the number of cells shown in 
Table I1 (Column 4) represent  a major fraction of the actual 
cells in  the extracts. 
Radioactivity recovered in cell pellets was >95% soluble in 
20% trichloroacetic acid, indicating that  it represented  almost 
exclusively degradation products entrapped inside cells. In 
control experiments, when cultured fibroblasts were mixed 
with the  supernatant from a collagenase extract of radioactive 
skin, <0.02% of the  total radioactivity was recovered in  the 
washed cell pellet. Furthermore, when the acid-soluble frac- 
tion from either cell pellets or digest supernatants was ana- 
lyzed for free iodide (8) 510% of the radioactivity was re- 
covered in  the free form. The  amount of acid-soluble degra- 
dation products recovered in cells is consistent with that 
predicted on the basis of acid precipitation of whole skin 
.(Table  I).  Thus, for the experiments in Table 11, the acid- 
soluble radioactivity in  the cell pellets represented 56% of the 
total radioactivity released, in reasonable agreement with the 
65% acid-soluble radioactivity measured in whole skin  (Table 
I). Another 24% of released radioactivity was recovered in 
acid-soluble form in the digest supernatants. Some of this 
soluble radioactivity undoubtedly arises from leakage of deg- 
radation  products from cells, but may also arise from degra- 
dation of intact  protein  during the collagenase digestion. In a 
control experiment, when lZ5I-DLT-RSA was mixed with a 
digestion extract  and incubated for 30 min, about 10% of the 
radioactivity was converted to acid-soluble form. 
In some experiments, the radioactive cell pellets from sep- 
arate digestions were transferred to individual culture flasks 
and incubated overnight at 37 "C for recovery of fibroblasts. 
In these  experiments, an average of 27 and 15% of the cells 
and radioactivity, respectively, seeded in  the flasks was re- 
covered after  trypsinization of adherent cells on the following 
day. Many of the cells attached to  the culture flasks exhibited 
typical fibroblast morphology although  they were also highly 
vacuolated, probably because of the HEPES buffer (9) used 
to maintain  pH during the digestion of skin. Since fibroblasts 
are expected to be the major adhering cell type from cultures 
of skin cells, the results  are qualitatively consistent with the 
hypothesis, but do not prove, that radioactive degradation 
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TABLE I1 
Recovery of radioactivity  and cells following sequential  colhgenase 
digests of skin  from  rats  injected  with ’=I-DLT-RSA 
Animals ( n  = 3) were  injected  with -160 X lo6 cpm of ‘%I-DLT- 
RSA  and  killed after 4 days,  and skin was  digested  with  collagenase 
as described  under  “Materials  and  Methods.” 
Digest‘ counts/min* cell pellet“ (x10-6) 
Total Counts/min in Number of cells Counts/min/cell~ 
% % 
1. 17.0 f 3.9 51.1 f 6.6 0.99 f .28 0.21 
2.  9.0 +- 2.4 61.3 f 7.3 1.52 f .45 0.08 
3. 9.6 4 3.6 40.2 f 3.8 1.62 f .2 0.21 
4. 10.3 k 1.0 66.5 f 6.8 1.94 f .13 0.14 
5. 8.8k 1.6 64.1 f 5.4 1.35 f .1 0.17 
6.  9. +- 3.0 77.5 f 2.5 2.14 f .24 0.13 
“Digests were harvested at 30-min intervals after the 1st h as 
described  under  “Material and Methods.” 
* Radioactivity in each  digest was divided  by the sum of radioactiv- 
ity in all  digests  and in undigested  skin.  Total  radioactivity  in  skin 
samples  was 2-4 X lo6 cpm. 
E Cells were separated from the digest by centrifugation, resus- 
pended in fresh  medium, and recentrifuged, and the counts/min in 
the washed cell pellet was divided  by the total radioactivity in the 
original  digest. 
Data shown is for one animal, since the value for counts/min/cell 
will  depend on absolute  amount of radioactivity  injected  and  size of 
the animal. An approximate 2-fold range in counts/min/cell was 
typical  in  these  experiments. 
products are recovered in fibroblasts alone. Efforts to increase 
the yield of viable cells plated from the collagenase digests 
have not been fruitful. 
As another  means to identify the cells containing radioac- 
tive degradationproducts, several different collagenase digests 
of skin were subjected to centrifugation on a continuous 
metrizamide density gradient. In control experiments, it was 
established that normal rat skin fibroblasts isolated from a 
culture flask by trypsinization  banded primarily at fractions 
4-6, whereas white cells in peripheral rat blood banded at 
fractions 6-7 and red blood cells were recovered near the 
bottom of the gradient  in  fraction 8. The histograms in Fig. 3 
show that  the majority of the recovered cells (-92%) and 
radioactivity (-81%) was associated with fractions 3-5. Al- 
though the majority of cultured fibroblasts peaked one frac- 
tion below the peak of primary isolates (4 uersm 3 ) ,  we 
attribute  the differences in migration on the gradient  primar- 
ily to  the fact that  the freshly isolated cells are highly vacuo- 
lated (see above), and thus likely to have a higher water 
content, making them slightly less dense. Only a limited 
amount (<lo%) of cells or radioactivity from skin was re- 
covered in  the region of the gradient associated with blood 
leukocytes. No overall differences in  the gradient profiles were 
observed if the digest was isolated from an early (digest 2) as 
compared to a late (digest 5 )  harvest from skin.  There is an 
indication that there was preferential association of the ra- 
dioactivity with the lighter fibroblast bands,  but the signifi- 
cance of this observation is  not yet clear. It can be noted from 
the autoradiographic studies that not  all fibroblasts contain 
degradation products, and  thus  the centrifugation technique 
may  be useful for selecting a fraction of cells which is more 
active in  albumin  uptake and catabolism. 
DISCUSSION 
The present studies with lZ5I-DLT labeled albumin have 
confirmed our  earlier  studies with the residualizing label, [3H] 
raffinose (l), and identify skin  and muscle as  primary  sites of 
albumin catabolism in  the  rat. Although the tissue pattern of 
albumin degradation is  similar  in  our two studies, there  are 
some differences between conclusions from  our work and  that 
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FIG. 3. Distribution of cells and  radioactivity  after  density 
gradient  centrifugation of cells isolated  from  rat skin. Two 
digests from each of the  three  experiments  described  in  Table I1 were 
subjected to centrifugation on metrizamide gradients as described 
under  “Materials  and  Methods.”  The tops of the blocks represent the 
means, and the bars the standard  deviations for recovered cells  and 
radioactivity from the six gradients.  Recovered  cells and radioactivity 
represented 71 k 17.2 and 72 f 7.3%, respectively, of the amounts 
applied.  Cultured rat skin  fibroblasts (Fb) banded at fractions 4-6, 
white  blood  cells ( W) from peripheral rat blood at fractions 6-7, and 
red  blood cells (R)  at fraction 8. 
on albumin catabolism in  the rabbit (lo), using [‘4C]sucrose 
coupled to protein with cyanuric chloride. In the rat, the 
contribution of liver to total albumin degradation was about 
lo%, based on the amount of catabolized dose recovered in 
liver, intestinal  contents, and feces, whereas in the rabbit, the 
value from these same sources totaled about 27%. It is likely, 
however, that  the contribution of the liver to albumin catab- 
olism in the rabbit is overestimated because of hepatic uptake 
of cyanuric chloride-derived degradation products released 
from peripheral tissues (2). Another difference between the 
rat and rabbit studies is in the relative roles of skin and 
muscle in albumin degradation. Thus,  in  the  rat, skin contrib- 
utes  about twice as much as muscle to overall albumin deg- 
radation, whereas the reverse was true in the rabbit (10). 
Although the source of these discrepancies regarding the 
quantitative role of the liver and other organs in albumin 
catabolism is not clear, residualizing labels have proven useful 
in  both  the  rat  and rabbit to establish that albumin is  cata- 
bolized diffusely, throughout the body, rather than in any 
specific tissue. In addition, in  the  rat, catabolites from lZ5I- 
DLT-albumin were entrapped sufficiently well inside fibro- 
blasts to allow isolation of these cells containing radioactive 
degradation products from skin. 
It should be noted that in all  studies to date (1, 10, this 
work) a significant fraction of radioactive degradation prod- 
ucts from albumin labeled with residualizing tracers is ex- 
creted  in  urine  and/or feces. Thus,  it is possible that a fraction 
of albumin catabolism occurs in  as yet unidentified tissues or 
cells from which the degradation products  are rapidly released. 
It is also possible that some albumin catabolism may take 
7994 Catabolism of Albumin by Fibroblasts in Vivo 
place extracellularly, e.g. at  the cell surface by membrane- 
bound proteases, or in extracellular fluid by soluble proteases. 
Residualizing labels would not identify these  sites of albumin 
degradation, since the degradation products would eventually 
be excreted through the kidney or liver. With  the development 
of residualizing labels which are  entrapped more efficiently in 
cells, it may be possible not only to identify other cell types 
active in albumin degradation, but also to assess the signifi- 
cance of albumin catabolism in  the extracellular space. 
The present  studies with lZ5I-DLT-RSA identify the fibro- 
blast as a major cell type involved in albumin catabolism, 
both by autoradiographic identification of radioactive fibro- 
blasts in tissues and by density  gradient isolation of radioac- 
tive fibroblasts from skin. Our results  support the hypothesis 
that  the catabolism of albumin  in  fibroblasts may  be physio- 
logically important  as  a source of amino acids for parenchymal 
cells in muscle, skin, and  other extrahepatic tissues. Thus, 
the liver, which serves a central role in the synthesis and 
distribution of carbohydrate and lipid fuels for peripheral 
tissues, may also secrete albumin as a reservoir of amino acids 
for use in these tissues. This hypothesis is  consistent with the 
observed net flux of amino acids from extrahepatic tissue 
toward the liver and the decrease in plasma amino acid 
concentrations during transit through liver (11). There are 
also interesting parallels in  the regulation of carbohydrate, 
lipid, and albumin reserves in  the body. Thus,  the synthesis 
of glycogen, triglyceride, and albumin (12, 13) is highly sen- 
sitive to regulation by insulin, and synthesis of these mole- 
cules rapidly decreases in response to protein  starvation and 
diabetes. In contrast, whereas the catabolism of glycogen and 
triglycerides is enhanced in  starvation  and diabetes, the ca- 
tabolism of albumin is suppressed (3). Further studies are  in 
progress to characterize the mechanisms regulating albumin 
catabolism in fibroblasts. 
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